Abstract: Systems and methods for pressure differential measurement and hemodynamic response assessment in vascular lumens are disclosed. Systems include catheter-based devices with variable flow restriction to create a controlled variable pressure differential (?P) within the coronary sinus. Methods are disclosed that allow a range of pressure changes to be mapped to a range of flow restriction diameters on a patient-specific basis as well as mapped to clinically measurable indicators of restriction/pressure change effect on hemodynamic and cardiac response.

Abstract: The present technology relates to systems and methods for removing a thrombus from a blood vessel of a patient. In some embodiments, the present technology is directed to systems including an elongated catheter having a distal portion configured to be positioned within the blood vessel of the patient, a proximal portion configured to be external to the patient, and a lumen extending therebetween. The system can also include an imaging element at the distal portion, an illumination source at the distal portion, a capture element at the distal portion and configured to engage the thrombus, a fluid delivery mechanism within the lumen and configured to apply fluid to (1) at least partially fragment the thrombus and (2) provide an optical path for the imaging element, and an aspiration mechanism fluidly coupled to the lumen and configured to aspirate the fragmented thrombus.

Abstract: Disclosed are vascular flow modulators generally comprised of an expandable scaffold with built-in adjustability to modulate hemodynamic output inside a vessel, for instance, the coronary sinus. Methods of placing and adjusting disclosed flow modulators are also disclosed.

Abstract: A device for occluding a patient's left atrial appendage (LAA) device includes a self-expanding closure disc and an anchor. The self-expanding closure disc has an atrial side, an appendage side, and a peripheral edge configured to engage tissue on both an atrial side and an appendage side of an opening between the left atrium and the left atrial appendage. The self-expanding anchor extends from the appendage side of the self-expanding closure disc, and an annular sealing skirt extends about at least a portion of the appendage side of the self-expanding closure disc. the annular sealing skirt is more compliant than the self-expanding closure disc to seal over the left appendage side of the opening after implantation of the device in the LAA.

Abstract: Systems and methods for localized drug delivery via undulating drug coated balloons (DCB), in particular using functionalized nanoparticles as a drug delivery medium in combination with an undulating balloon, are disclosed. In various disclosed embodiments, a nanoparticle matrix is adhered to in an external substrate-surface, such as the balloon surface, and is activated for release once at the treatment site. Activation for release may be enhanced through the use of an undulating balloon system including methodologies for precise control of timing, waveform and extent of undulations.

Abstract: The present technology is generally directed to interatrial shunting systems and associated devices and methods. For example, a system configured in accordance with embodiments of the present technology can include a shunting element implantable into a patient at or adjacent a septal wall. The shunting element can have a lumen that fluidly connects a left atrium and a right atrium of the patient to facilitate blood flow therebetween when the shunting element is implanted. In some embodiments, the system further includes a flow control element to selectively control blood flow between the left atrium and the right atrium.

Abstract: The present technology relates to interatrial shunting systems and methods. In some embodiments, the present technology includes a system for shunting blood between a left atrium and a right atrium of a patient. The system can include a shunting element having a lumen extending therethrough. The lumen is configured to fluidly couple the left atrium and the right atrium when the shunting element is implanted in the patient. The system can also include a sensor configured to be implanted in the patient and operably coupled to the shunting element. An actuation element is coupled to the sensor. The actuation element is configured to be selectively energized and transmit a desired motion to the sensor to reduce the likelihood of tissue ingrowth/overgrowth and adhesion on at least a portion of the sensor.

Abstract: Implant device recharging methods, devices, and systems. The implantable devices that are recharged can include one or more sensors. The implantable devices can include one or more receive transducers. A recharging catheter can emit energy to the one or more receive transducers to recharge an implantable device power source.

Abstract: The present technology generally relates to hemodynamic monitoring devices, as well as delivery systems adapted for the implantation of implantable pressure sensors or other implantable devices. In some embodiments, for example, the present technology includes a method of implanting a pressure sensing implant in a human patient. The method includes intravascularly advancing a delivery device carrying the pressure sensing implant toward a pulmonary artery of the patient, and sensing pressure in at least one of a right atrium, a right ventricle, and the pulmonary artery of the patient using a pressure sensing device carried by the delivery device. Sensing the pressure occurs before the pressure sensing implant is fully deployed in the pulmonary artery from the delivery device.

Abstract: Embodiments of device for monitoring pressure in the left atrium are provided. The device is delivered to the left atrium via the coronary sinus. A first portion of the device is deployed in the left atrium, the first portion of the device comprising a pressure sensor. A second portion of the device is deployed in the coronary sinus. Monitoring left atrial pressure via coronary sinus access can provide a safer, less invasive way to monitor a patient for heart failure.